Cargando…

Receptor-targeted therapy of human experimental urinary bladder cancers with cytotoxic LH-RH analog AN-152 (AEZS-108)

Many bladder cancers progress to invasion with poor prognosis; new therapeutic methods are needed. We developed a cytotoxic LH-RH analog, AN-152 (AEZS-108) containing doxorubicin (DOX), for targeted therapy of cancers expressing LHRH receptors. We investigated the expression of LH-RH receptors in cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szepeshazi, Karoly, Schally, Andrew V., Keller, Gunhild, Block, Norman L., Benten, Daniel, Halmos, Gabor, Szalontay, Luca, Vidaurre, Irving, Jaszberenyi, Miklos, Rick, Ferenc G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2012
Materias:	Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3443252/ https://www.ncbi.nlm.nih.gov/pubmed/22824624

Ejemplares similares

Powerful Inhibition of Experimental Human Pancreatic Cancers by Receptor Targeted Cytotoxic LH-RH analog AEZS-108
por: Szepeshazi, Karoly, et al.
Publicado: (2013)

Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone
por: Jaszberenyi, Miklos, et al.
Publicado: (2013)

Targeted cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), AEZS-108 (AN-152), inhibits the growth of DU-145 human castration-resistant prostate cancer in vivo and in vitro through elevating p21 and ROS levels
por: Popovics, Petra, et al.
Publicado: (2014)

Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125
por: Seitz, Stephan, et al.
Publicado: (2014)

The targeted LHRH analog AEZS-108 alters expression of genes related to angiogenesis and development of metastasis in uveal melanoma
por: Fodor, Klara, et al.
Publicado: (2020)

Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease
por: Jaszberenyi, Miklos, et al.
Publicado: (2012)

New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor
por: Kanashiro-Takeuchi, Rosemeire M., et al.
Publicado: (2015)

Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancers
por: Perez, Roberto, et al.
Publicado: (2012)

Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers
por: Szepeshazi, K, et al.
Publicado: (2000)

Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines
por: Sipos, Eva, et al.
Publicado: (2018)

New therapies for relapsed castration-resistant prostate cancer based on peptide analogs of hypothalamic hormones
por: Schally, Andrew V, et al.
Publicado: (2015)

Efficacy and Safety of AEZS-108 (LHRH Agonist Linked to Doxorubicin) in Women With Advanced or Recurrent Endometrial Cancer Expressing LHRH Receptors: A Multicenter Phase 2 Trial (AGO-GYN5)
por: Emons, Günter, et al.
Publicado: (2014)

Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
por: Pinski, J., et al.
Publicado: (1994)

The Effect of Photoperiodic Conditions on GnRH/LH Secretion in Ewes
por: Kopycińska, Kamila, et al.
Publicado: (2022)

Effective treatment of experimental U-87MG human glioblastoma in nude mice with a targeted cytotoxic bombesin analogue, AN-215
por: Szereday, Z, et al.
Publicado: (2002)

An update on the use of degarelix in the treatment of advanced hormone-dependent prostate cancer
por: Rick, Ferenc G, et al.
Publicado: (2013)

Early Treatment of Hypothalamic Hypogonadism With LH-RH Analog Improved the Long-Term Prognosis of Hypogonadism of Adult-Onset Craniopharyngioma
por: Iwabuchi, Masayasu
Publicado: (2021)

Using Aptamers as a Novel Method for Determining GnRH/LH Pulsatility
por: Izzi-Engbeaya, Chioma, et al.
Publicado: (2020)

The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer.
por: Williams, M. R., et al.
Publicado: (1986)

Orchiectomy versus medical therapy with LH-RH analogues for the treatment of advanced prostatic carcinoma
por: Rohde, Volker, et al.
Publicado: (2006)

Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers
por: Bajo, A M, et al.
Publicado: (2004)

SUN-265 Performance of Basal and GnRH Analog-Stimulated LH Levels Assessed by an Electrochemiluminescence Assay in Girls with Central Precocious Puberty
por: Faria, Aline, et al.
Publicado: (2019)

A mathematical model for LH release in response to continuous and pulsatile exposure of gonadotrophs to GnRH
por: Washington, Talitha M, et al.
Publicado: (2004)

A Two-Pathway Mathematical Model of the LH Response to GnRH that Predicts Self-Priming
por: Evans, J. J., et al.
Publicado: (2013)

Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists
por: Chatzistamou, I, et al.
Publicado: (2000)

Eel Kisspeptins: Identification, Functional Activity, and Inhibition on both Pituitary LH and GnRH Receptor Expression
por: Pasquier, Jérémy, et al.
Publicado: (2018)

Determination of Half-lives of Circulating FSH and LH Glycoforms in Women During GnRH Receptor Blockade
por: Wide, Leif, et al.
Publicado: (2022)

The value of LH maximum level in predicting optimal oocyte yield following GnRH agonist trigger
por: Lee, William Hao-Yu, et al.
Publicado: (2023)

Novel Crizotinib–GnRH Conjugates Revealed the Significance of Lysosomal Trapping in GnRH-Based Drug Delivery Systems
por: Murányi, József, et al.
Publicado: (2019)

Targeted cytotoxic analogue of bombesin/ gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice
por: Kiaris, H, et al.
Publicado: (1999)

Macimorelin (AEZS-130)-Stimulated Growth Hormone (GH) Test: Validation of a Novel Oral Stimulation Test for the Diagnosis of Adult GH Deficiency
por: Garcia, J. M., et al.
Publicado: (2013)

R108
por: CERN PhotoLab
Publicado: (1976)

At R108
por: CERN PhotoLab
Publicado: (1977)

At R108
por: CERN PhotoLab
Publicado: (1977)

At R108
por: CERN PhotoLab
Publicado: (1977)

LH and testosterone secretions in response to GnRH challenge in pubertal Japanese Black beef bulls with normal and abnormal semen
por: SAKASE, Mitsuhiro, et al.
Publicado: (2018)

LhANS-rr1, LhDFR, and LhMYB114 Regulate Anthocyanin Biosynthesis in Flower Buds of Lilium ‘Siberia’
por: Fang, Shaozhong, et al.
Publicado: (2023)

Individualized Treatment from Theory to Practice: The Private Case of Adding LH during GnRH Antagonist-based Stimulation Protocol
por: Kol, Shahar
Publicado: (2014)

Anovulatory Patients Demonstrate a Sharp Decline in LH Levels upon GnRH Antagonist Administration during IVF Cycles
por: Segal, Linoy, et al.
Publicado: (2017)

LH Levels May Be Used as an Indicator for the Time of Antagonist Administration in GnRH Antagonist Protocols—A Proof-Of-Concept Study
por: Liu, Minghui, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3a10ihjfbrpamdhieor8nfronm